Position in NTRA
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,465,851
+$910,129 QoQ
Shares Held
9,084
+16.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#342
of 844 holders
Holding Since
Dec 2023
10 quarters on record
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $23,609,326 across 14 Diagnostics & Research names. NTRA ranks #4 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,955 | $5,993,758 | |
| 2 | DHR |
Danaher Corp /De/
|
15,367 | $2,927,106 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
12,885 | $2,489,639 | |
| 4 | NTRA |
Natera, Inc.
This page
|
9,084 | $2,465,851 | |
| 5 | DGX |
Quest Diagnostics Inc
|
9,611 | $2,037,051 | |
| 6 | A |
Agilent Technologies, Inc.
|
11,890 | $1,579,348 | |
| 7 | LH |
Labcorp Holdings Inc.
|
5,179 | $1,450,120 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
2,395 | $1,268,368 |
All Filings in NTRA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,465,851 | 9,084 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,555,722 | 7,779 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,904,425 | 8,313 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $1,394,000 | 8,660 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,525,359 | 9,029 | Shares | Sole | 2025-07-14 | |
| 2024-12-31 | $1,392,090 | 8,794 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $994,399 | 7,833 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $739,404 | 6,828 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $490,957 | 5,368 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $286,202 | 4,569 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||